New
Concepts in Post-Infarction Ventricular Remodeling
James Udelson,
MD
Associate Chief of Cardiology
Tufts-New England
Medical Center
Boston, MA
Reappraisal
of Beta-Blocker Therapy in the Acute and Chronic Post-Myocardial
Infarction Period
Mihai Gheorghiade, MD, FACC, FACP
Associate Chief, Division of Cardiology
Professor of Medicine, Northwestern University Medical School
Chicago, IL
The
New Evidence
from the
CAPRICORN
Trial: The
Role of Carvedilol
in High-Risk,
Post-Myocardial
Infarction
Patients Jonathan
Sackner-Bernstein,
MD
Heart Failure and Cardiomyopathy Center
North Shore University Hospital
Manhasset, NY
Diabetes,
Hypertension,
and
Renal
Insufficiency
in
Post-Myocardial
Cardiovascular
Risk William
T.
Abraham,
MD
Chief
of
Cardiology,
Ohio
State
University
Medical
Center
Columbus,
OH
The
Role
of
In-Hospital
Initiation
of
Cardiovascular
Protective
Therapies
to
Improve
Treatment
Rates
and
Clinical
Outcomes
Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center
Director, UCLA Cardiology Fellowship Training Program
Los Angeles, CA
Critical
Pathways
for
Acute
Myocardial
Infarction Christopher
P.
Cannon,
MD
Assistant Professor of Medicine, Harvard Medical School
Boston, MA
Roundtable
Discussion
William
T.
Abraham,
MD
Mihai
Gheorghiade,
MD,
FACC,
FACP
Gregg C. Fonarow, MD
